Filing Details

Accession Number:
0001415889-24-023609
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-09-18 16:15:14
Reporting Period:
2024-09-16
Accepted Time:
2024-09-18 16:15:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1953926 Zenas Biopharma Inc. ZBIO () DE
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1953107 Enavate Sciences Gp, Llc 2882 Sand Hill Road, Suite 100
Menlo Park CA 94025
No No No No
2037042 Zebra Aggregator, Lp 106 West 56Th Street, 8Th Floor
New York NY 10019
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-09-16 2,879,006 $0.00 2,879,006 No 4 C Indirect By Zebra Aggregator, LP
Common Stock Acquisiton 2024-09-16 882,353 $17.00 3,761,359 No 4 P Indirect By Zebra Aggregator, LP
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Zebra Aggregator, LP
No 4 P Indirect By Zebra Aggregator, LP
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series B Preferred Stock Disposition 2024-09-16 10,474,889 $0.00 1,206,353 $0.00
Common Stock Series C Preferred Stock Disposition 2024-09-16 14,523,821 $0.00 1,672,653 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. Each share of Series B Preferred Stock and Series C Preferred Stock (collectively, the "Preferred Stock") converted into shares of Common Stock of the Issuer on an 8.6831-for-one basis without payment of further consideration. Immediately prior to the closing of the Issuer's initial public offering, the Preferred Stock was converted into the number of shares of Common Stock of the Issuer shown in column 7 of Table II. The Preferred Stock has no expiration date.
  2. Shares are directly held by Zebra Aggregator, LP ("Zebra"). Enavate Sciences GP, LLC ("Enavate") is the general partner of Zebra and may be deemed to share voting and investment power with respect to the shares held by Zebra. Enavate disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purpose.